Creative Life Science Co (ROCO:7837) LT-Debt-to-Total-Asset: 0.20 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7837 Creative Life Science Co Ltd ROCO:7837
20 GF Score
Price NT$71.00
! 3 Warning Signs
View Full Analysis

What is Creative Life Science Co LT-Debt-to-Total-Asset?

Creative Life Science Co ROCO:7837 +2.75% 20 LT-Debt-to-Total-Asset is 0.20 as of Dec. 2025. GuruFocus rates ROCO:7837 with a GF Score™ of 20/100. The stock has 3 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Creative Life Science Co's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.20.

Creative Life Science Co's long-term debt to total assets ratio declined from Dec. 2024 (0.24) to Dec. 2025 (0.20). It may suggest that Creative Life Science Co is progressively becoming less dependent on debt to grow their business.

Creative Life Science Co  (ROCO:7837) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Creative Life Science Co LT-Debt-to-Total-Asset Related Terms

Creative Life Science Co LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Creative Life Science Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creative Life Science Co LT-Debt-to-Total-Asset Chart

Creative Life Science Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
0.06 0.11 0.27 0.24 0.20

Creative Life Science Co Semi-Annual Data
Dec21 Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
LT-Debt-to-Total-Asset Get a 7-Day Free Trial 0.27 0.00 0.24 0.21 0.20
ROCO:7837
20GF Score
Creative Life Science Co Ltd ROCO:7837
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Creative Life Science Co LT-Debt-to-Total-Asset Calculation

Creative Life Science Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=289.385/1439.135
=0.20

Creative Life Science Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )/Total Assets (Q: Dec. 2025 )
=289.385/1439.135
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.20 mean?
Creative Life Science Co (ROCO:7837) has a LT-Debt-to-Total-Asset of 0.20 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Creative Life Science Co and its competitors.
Is Creative Life Science Co's LT-Debt-to-Total-Asset too high?
Creative Life Science Co's current LT-Debt-to-Total-Asset is 0.20. Overall, Creative Life Science Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Creative Life Science Co's LT-Debt-to-Total-Asset compare to VRTX and REGN?
Creative Life Science Co's LT-Debt-to-Total-Asset of 0.20 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Biotechnology company?
A good LT-Debt-to-Total-Asset depends on the Biotechnology industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Creative Life Science Co and its competitors. Creative Life Science Co's current LT-Debt-to-Total-Asset is 0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creative Life Science Co stock overvalued right now?
Creative Life Science Co (ROCO:7837) has a current LT-Debt-to-Total-Asset of 0.20. The current LT-Debt-to-Total-Asset is 0.20. Creative Life Science Co's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Creative Life Science Co (ROCO:7837), the current LT-Debt-to-Total-Asset is 0.20 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Creative Life Science Co Business Description

Address Wuquan 3rd Road, No. 24, Wugu District, New Taipei City, TWN, 248021
Creative Life Science Co Ltd is engaged in providing products of microbiology, and it has prepared media products and diagnostic reagents. The main products of CMP (Creative Media Plate) are solid and liquid media, which can be used for clinical microbiology, basic microbial research, environmental monitoring, biosafety testing, and quality control. Its product line is Transport Medium, Prepared Tube Media, Prepared Plated Media, VTM & I-VTM, Bacterial strain preservation system, and CMP SteriPack triple wrapped media.
20GF Score

Get the complete analysis for ROCO:7837

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$71.00
Price